Indoco Remedies Limited — Q1 FY26 earnings call

INDOCO To The Listing Department Bombay Stock Exchange Limited Floor 25, P. J. Towers, Dalal Street, Mumbai – 400 001

532612 Dear Sir/Madam, Subject: Intimation of Earnings Conference Call on Unaudited Financial Results for Quarter Ended 30th June, 2026 Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an Earnings Conference Call on Unaudited Financial Results for the Quarter Ended 30th June, 2026 is scheduled to be held on Tuesday, 28th July, 2026 at 03:30 P.M. IST. The details of the conference call are enclosed herewith. This is for your information and dissemination on respective websites. Thanking you, Yours faithfully, For Indoco Remedies Limited Ramanathan Hariharan Company Secretary & Head Legal RAMANATHA N HARIHARAN Digitally signed by RAMANATHAN HARIHARAN Date: 2026.07.17 12:04:53 +05'30' You are cordially invited to the Q1 FY2026-2027 Earnings Conference Call of Indoco Remedies Limited on Tuesday, July 28, 2026 at 3:30PM IST Represented by: Ms. Aditi Panandikar Mr. Sundeep V. Bambolkar Mr. Pramod Ghorpade Managing Director Jt. Managing Director CFO Pre-register to avoid the waiting queue, join with DiamondPass link: Registration Link Conference Dial-In Number Universal Access +91 22 6280 1116 +91 22 7115 8017 International Toll Free

800 964 448

800 101 2045

1 866 746 2133

0 808 101 1573 For further information, please contact: Rashmi Shetty Director - Research Dolat Capital Market Pvt. Ltd. (D) +91 22 40969724 (M) +91 22 8879111413

rashmis@dolatcapital.com Candice Pereira AVP Research Dolat Capital Market Pvt. Ltd. (D) +91 22 61764873 (M) +91 22 9833458572

candicep@dolatcapital.com Zain Gulam Hussain Associate Dolat Capital Market Pvt. Ltd. (D) +91 22 40969790 (M) +91 22 9892724209

zain@dolatcapital.com